1 Zara S, "Zoledronic acid at subtoxic dose extends osteoblastic stage span of primary human osteoblasts" 19 : 601-611, 2015
2 Benisch P, "The transcriptional profile of mesenchymal stem cell populations in primary osteoporosis is distinct and shows overexpression of osteogenic inhibitors" 7 : e45142-, 2012
3 Lee JH, "The inhibitory effect of zoledronate on early-stage osteoinduction by recombinant human bone morphogenetic protein 2 in an osteoporosis model" 33 : 220-228, 2015
4 Shoji KE, "The effect of bisphosphonates on the clinical and radiographic outcomes of distal radius fractures in women" 43 : 115-122, 2018
5 박예수, "The Effect of Zoledronic Acid on the Volume of the Fusion-Mass in Lumbar Spinal Fusion" 대한정형외과학회 5 (5): 292-297, 2013
6 Klein BY, "Structurally different bisphosphonates exert opposing effects on alkaline phosphatase and mineralization in marrow osteoprogenitors" 68 : 186-194, 1998
7 Zaidi M, "Skeletal remodeling in health and disease" 13 : 791-801, 2007
8 Casado-Diaz A, "Risedronate positively affects osteogenic differentiation of human mesenchymal stromal cells" 44 : 325-334, 2013
9 Plotkin LI, "Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin" 104 : 1363-1374, 1999
10 Rachner TD, "Osteoporosis: now and the future" 377 : 1276-1287, 2011
1 Zara S, "Zoledronic acid at subtoxic dose extends osteoblastic stage span of primary human osteoblasts" 19 : 601-611, 2015
2 Benisch P, "The transcriptional profile of mesenchymal stem cell populations in primary osteoporosis is distinct and shows overexpression of osteogenic inhibitors" 7 : e45142-, 2012
3 Lee JH, "The inhibitory effect of zoledronate on early-stage osteoinduction by recombinant human bone morphogenetic protein 2 in an osteoporosis model" 33 : 220-228, 2015
4 Shoji KE, "The effect of bisphosphonates on the clinical and radiographic outcomes of distal radius fractures in women" 43 : 115-122, 2018
5 박예수, "The Effect of Zoledronic Acid on the Volume of the Fusion-Mass in Lumbar Spinal Fusion" 대한정형외과학회 5 (5): 292-297, 2013
6 Klein BY, "Structurally different bisphosphonates exert opposing effects on alkaline phosphatase and mineralization in marrow osteoprogenitors" 68 : 186-194, 1998
7 Zaidi M, "Skeletal remodeling in health and disease" 13 : 791-801, 2007
8 Casado-Diaz A, "Risedronate positively affects osteogenic differentiation of human mesenchymal stromal cells" 44 : 325-334, 2013
9 Plotkin LI, "Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin" 104 : 1363-1374, 1999
10 Rachner TD, "Osteoporosis: now and the future" 377 : 1276-1287, 2011
11 Corrado A, "Neridronate and human osteoblasts in normal, osteoporotic and osteoarthritic subjects" 24 : 527-534, 2005
12 Pittenger MF, "Multilineage potential of adult human mesenchymal stem cells" 284 : 143-147, 1999
13 Brack AS, "Intrinsic changes and extrinsic influences of myogenic stem cell function during aging" 3 : 226-237, 2007
14 Orriss IR, "Inhibition of osteoblast function in vitro by aminobisphosphonates" 106 : 109-118, 2009
15 서중배, "Influence of Early Bisphosphonate Administration for Fracture Healing in Patients with Osteoporotic Proximal Humerus Fractures" 대한정형외과학회 8 (8): 437-443, 2016
16 Pozzi S, "High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties" 15 : 5829-5839, 2009
17 Malavasi M, "Effects of risedronate on osteoblastic cell cultures" 68 : 43-47, 2016
18 Seiji Ohtori, "Does Discontinuing Teriparatide Treatment and Replacing It with Bisphosphonate Maintain the Volume of the Bone Fusion Mass after Lumbar Posterolateral Fusion in Women with Postmenopausal Osteoporosis?" 대한척추외과학회 11 (11): 272-277, 2017
19 Michael A. Stone, "Bisphosphonate’s and Intermittent Parathyroid Hormone’s Effect on Human Spinal Fusion: A Systematic Review of the Literature" 대한척추외과학회 11 (11): 484-493, 2017
20 Maruotti N, "Bisphosphonates: effects on osteoblast" 68 : 1013-1018, 2012
21 Li B, "Bisphosphonates, specific inhibitors of osteoclast function and a class of drugs for osteoporosis therapy" 112 : 1229-1242, 2011
22 Viereck V, "Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts" 291 : 680-686, 2002
23 Reinholz GG, "Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts" 60 : 6001-6007, 2000
24 Holder KK, "Alendronate for fracture prevention in postmenopause" 78 : 579-581, 2008
25 Kim HK, "Alendronate enhances osteogenic differentiation of bone marrow stromal cells: a preliminary study" 467 : 3121-3128, 2009
26 Sethe S, "Aging of mesenchymal stem cells" 5 : 91-116, 2006
27 Muschler GF, "Age- and genderrelated changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors" 19 : 117-125, 2001